BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9493060)

  • 21. Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers?
    Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH;
    Reprod Biomed Online; 2019 Jun; 38(6):938-942. PubMed ID: 30981620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.
    Checa MA; Prat M; Robles A; Carreras R
    Fertil Steril; 2006 Mar; 85(3):573-7. PubMed ID: 16500321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility.
    Checa MA; Prat M; Carreras R
    Fertil Steril; 2010 Aug; 94(3):1105-7. PubMed ID: 20045519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
    Vlahos NF; Coker L; Lawler C; Zhao Y; Bankowski B; Wallach EE
    Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
    Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
    PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination.
    Moro F; Tropea A; Scarinci E; Leoncini E; Boccia S; Federico A; Alesiani O; Lanzone A; Apa R
    Int J Gynaecol Obstet; 2016 Apr; 133(1):64-8. PubMed ID: 26873125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.
    Dansuk R; Gonenc AI; Sudolmus S; Yucel O; Sevket O; Köroğlu N
    Singapore Med J; 2015 Jun; 56(6):353-6. PubMed ID: 25532515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial insemination. Role of endometrial thickness and pattern, of vascular impedance of the spiral and uterine arteries, and of the dominant follicle.
    Tsai HD; Chang CC; Hsieh YY; Lee CC; Lo HY
    J Reprod Med; 2000 Mar; 45(3):195-200. PubMed ID: 10756496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination.
    Danhof NA; van Wely M; Koks CAM; Gianotten J; de Bruin JP; Cohlen BJ; van der Ham DP; Klijn NF; van Hooff MHA; Broekmans FJM; Fleischer K; Janssen CAH; Rijn van Weert JM; van Disseldorp J; Twisk M; Traas M; Verberg MFG; Pelinck MJ; Visser J; Perquin DAM; Boks DES; Verhoeve HR; van Heteren CF; Mol BWJ; Repping S; van der Veen F; Mochtar MH
    BMJ Open; 2017 May; 7(5):e015680. PubMed ID: 28550023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new system for fallopian tube sperm perfusion leads to pregnancy rates twice as high as standard intrauterine insemination.
    Fanchin R; Olivennes F; Righini C; Hazout A; Schwab B; Frydman R
    Fertil Steril; 1995 Sep; 64(3):505-10. PubMed ID: 7641902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment.
    Houmard BS; Juang MP; Soules MR; Fujimoto VY
    Fertil Steril; 2002 Feb; 77(2):384-6. PubMed ID: 11821101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N; Sylvestre C; Tulandi T; Buckett W
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.
    Erdem M; Abay S; Erdem A; Firat Mutlu M; Nas E; Mutlu I; Oktem M
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
    Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
    Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates.
    Gratton RJ; Nisker JA; Daniel S; Toth S; Gunter J; Kaplan BR; Tummon IS; Yuzpe AA
    Hum Reprod; 1993 Apr; 8(4):528-31. PubMed ID: 8501179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism.
    Huseyin K; Berk B; Tolga K; Eser O; Ali G; Murat A
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):833-838. PubMed ID: 30930300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus late hCG administration to trigger ovulation in mild stimulated IUI cycles: a randomized clinical trial.
    da Silva AL; Arbo E; Fanchin R
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):156-60. PubMed ID: 22743137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles.
    Shalev E; Geslevich Y; Matilsky M; Ben-Ami M
    Hum Reprod; 1995 Sep; 10(9):2244-7. PubMed ID: 8530644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of follicle number, serum estradiol level, and other factors to clinical pregnancy rate in gonadotropin-induced intrauterine insemination cycles.
    Ozçakir HT; Göker EN; Terek MC; Adakan S; Ulukus M; Levi R; Tavmergen E
    Arch Gynecol Obstet; 2002 Jan; 266(1):18-20. PubMed ID: 11998958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.